Analystreport

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) had its price target lowered by analysts at Robert W. Baird from $8.00 to $7.00.

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com